Taro Takami Selected Research

Hypertension (High Blood Pressure)

11/2023	Portopulmonary Hypertension Treated by Occlusion of a Spontaneous Portosystemic Shunt Followed by Endothelin Receptor Antagonist Administration.
10/2021	Successful Management With Dual Therapy of Lenvatinib and Macitentan for HCC With Portopulmonary Hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taro Takami Research Topics

Disease

29	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 09/2003
24	Neoplasms (Cancer) 12/2023 - 10/2007
24	Liver Cirrhosis (Hepatic Cirrhosis) 11/2023 - 02/2004
22	Fibrosis (Cirrhosis) 12/2023 - 01/2004
12	Liver Diseases (Liver Disease) 11/2022 - 02/2004
8	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 01/2016
6	Hypoxia (Hypoxemia) 05/2020 - 03/2016
5	End Stage Liver Disease 01/2023 - 01/2019
5	Portal Hypertension 01/2023 - 09/2014
4	Fatty Liver 09/2021 - 01/2017
3	Inflammation (Inflammations) 11/2023 - 10/2011
3	Non-alcoholic Fatty Liver Disease 11/2023 - 09/2014
3	Infections 11/2022 - 06/2014
3	Hepatic Encephalopathy 03/2022 - 09/2014
3	Colorectal Neoplasms (Colorectal Cancer) 03/2020 - 04/2018
2	Hypertension (High Blood Pressure) 11/2023 - 10/2021
2	Liver Neoplasms (Liver Cancer) 10/2023 - 03/2020
2	Crohn Disease (Crohn's Disease) 12/2022 - 01/2022
2	Mitochondrial Diseases (Mitochondrial Disease) 07/2022 - 05/2020
2	Colitis 06/2022 - 01/2017
2	Pancreatic Diseases (Pancreatic Disease) 01/2022 - 01/2021
2	Liver Failure 10/2020 - 02/2020
2	Hyperammonemia 10/2020 - 11/2019
2	Weight Loss (Weight Reduction) 07/2019 - 01/2016
2	Ascites 07/2019 - 07/2017
2	Genomic Instability 05/2019 - 01/2018
2	Cholangiocarcinoma 01/2015 - 01/2014
2	Insulin Resistance 10/2014 - 09/2014
2	Carcinogenesis 10/2011 - 10/2007
1	Obesity 01/2024
1	Cicatrix (Scar) 12/2023
1	Cadaver (Cadavers) 11/2023
1	Necrosis 08/2023
1	Ulcerative Colitis 08/2023
1	Lymphadenopathy 07/2023
1	Hemangiosarcoma (Angiosarcoma) 07/2023
1	Disease Progression 05/2023

Drug/Important Bio-Agent (IBA)

11	IronIBA 12/2023 - 05/2014
10	Chelating AgentsIBA 12/2023 - 05/2014
10	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2018
9	Sorafenib (BAY 43-9006)FDA Link 01/2024 - 05/2016
7	Deferasirox FDA Link 12/2023 - 01/2016
7	Antiviral Agents (Antivirals)IBA 12/2023 - 01/2016
7	Amino Acids FDA Link 11/2020 - 02/2004
6	Biomarkers (Surrogate Marker)IBA 10/2023 - 03/2018
6	Deferoxamine (Desferal)FDA LinkGeneric 05/2022 - 05/2014
6	Choline (Choline Chloride)IBA 11/2020 - 02/2004
5	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2020 - 10/2011
5	CDAA (Randox)IBA 11/2020 - 02/2004
4	lenvatinibIBA 01/2024 - 03/2020
4	SodiumIBA 01/2023 - 01/2019
4	Therapeutic UsesIBA 05/2020 - 06/2012
4	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 10/2016 - 10/2007
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2011
3	hydrogen sulfite (bisulfite)IBA 01/2021 - 03/2018
3	Indicators and Reagents (Reagents)IBA 05/2020 - 01/2018
3	DiureticsIBA 11/2019 - 07/2017
3	Tolvaptan FDA Link 07/2019 - 01/2016
3	EnzymesIBA 01/2018 - 02/2004
3	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 09/2003
2	AlbuminsIBA 01/2024 - 01/2021
2	LipidsIBA 11/2023 - 01/2017
2	C-Reactive ProteinIBA 08/2023 - 01/2022
2	Bevacizumab (Avastin)FDA Link 07/2023 - 05/2023
2	atezolizumabIBA 07/2023 - 05/2023
2	Tumor Biomarkers (Tumor Markers)IBA 05/2023 - 01/2004
2	BilirubinIBA 05/2022 - 01/2021
2	Cyclin D1IBA 02/2022 - 06/2013
2	Carrier Proteins (Binding Protein)IBA 02/2022 - 02/2020
2	Serum AlbuminIBA 01/2022 - 03/2013
2	Messenger RNA (mRNA)IBA 11/2020 - 10/2016
2	AmmoniaIBA 10/2020 - 09/2017
2	Cell-Free Nucleic AcidsIBA 03/2020 - 03/2018
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 03/2018
2	Branched-Chain Amino AcidsIBA 11/2019 - 08/2016
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2019 - 01/2017
2	Gemcitabine FDA Link 06/2018 - 01/2014
2	Vitamin A (Retinol)FDA LinkGeneric 01/2017 - 08/2016
2	CreatinineIBA 10/2016 - 01/2016
2	Fluorouracil (Carac)FDA LinkGeneric 01/2014 - 09/2003
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2012 - 01/2011
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2012 - 05/2012
1	CholesterolIBA 11/2023
1	Endothelin Receptor AntagonistsIBA 11/2023
1	Trace Elements (Biometals)IBA 10/2023
1	TAC AlternateIBA 08/2023
1	AntibodiesIBA 08/2023
1	Calcineurin InhibitorsIBA 08/2023
1	Mesalamine (Mesalazine)FDA LinkGeneric 08/2023
1	Tacrolimus (Prograf)FDA LinkGeneric 08/2023

Therapy/Procedure

32	Therapeutics 01/2024 - 01/2011
15	Drug Therapy (Chemotherapy) 11/2022 - 09/2003
6	Surgical Portasystemic Shunt (Portosystemic Shunt) 11/2023 - 09/2014
5	Liver Transplantation 11/2020 - 07/2012
3	Local Anesthesia 06/2014 - 01/2011
2	Injections 07/2022 - 10/2014
2	Aftercare (After-Treatment) 07/2022 - 06/2018
1	Neoadjuvant Therapy 03/2024
1	Traction 12/2023
1	Remission Induction 08/2023